Vical Inc. (NASDAQ:VICL)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a report issued on Sunday.
Separately, Zacks Investment Research lowered shares of Vical from a “buy” rating to a “hold” rating in a research note on Wednesday, October 12th.
Vical (NASDAQ:VICL) traded down 0.38% during midday trading on Friday, hitting $2.63. 16,488 shares of the stock traded hands. Vical has a 12-month low of $2.27 and a 12-month high of $5.35. The company’s 50-day moving average is $2.69 and its 200 day moving average is $3.71. The firm’s market cap is $29.06 billion.
Vical (NASDAQ:VICL) last announced its quarterly earnings data on Thursday, November 3rd. The company reported ($0.24) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.25) by $0.01. Vical had a negative net margin of 47.06% and a negative return on equity of 19.11%. The firm earned $2.60 million during the quarter, compared to analyst estimates of $4.60 million. On average, analysts anticipate that Vical will post ($0.86) EPS for the current fiscal year.
Several hedge funds have recently modified their holdings of the company. BlackRock Fund Advisors boosted its stake in shares of Vical by 32.5% in the second quarter. BlackRock Fund Advisors now owns 23,459 shares of the company’s stock valued at $106,000 after buying an additional 5,750 shares in the last quarter. BlackRock Institutional Trust Company N.A. boosted its stake in shares of Vical by 2.9% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 335,163 shares of the company’s stock valued at $1,019,000 after buying an additional 9,489 shares in the last quarter. ClariVest Asset Management LLC boosted its stake in shares of Vical by 53.5% in the third quarter. ClariVest Asset Management LLC now owns 70,707 shares of the company’s stock valued at $215,000 after buying an additional 24,655 shares in the last quarter. Eagle Global Advisors LLC acquired a new stake in shares of Vical during the second quarter valued at about $178,000. Finally, Renaissance Technologies LLC boosted its stake in shares of Vical by 29.8% in the first quarter. Renaissance Technologies LLC now owns 2,073,599 shares of the company’s stock valued at $811,000 after buying an additional 476,499 shares in the last quarter. 26.42% of the stock is currently owned by institutional investors and hedge funds.
Vical Company Profile